|
| Press Releases |
|
 |
|
| Monday, July 25, 2022 |
|
|
医思健康料2023财年第一季度录得销售额不少于8.6亿港元 同比升不少于17% |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团预计2022年4月至6月期间（「季内」）录得不少于8.6亿港元的销售额，同比上升不少于17%。 more info >> |
|
|
醫思健康料2023財年第一季度錄得銷售額不少於8.6億港元 同比升不少於17% |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團預計2022年4月至6月期間（「季內」）錄得不少於8.6億港元的銷售額，同比上升不少於17%。 more info >> |
|
|
EC Healthcare expects sales volume to increase no less than 17% Y-o-Y to no less than HK$860 million in the first quarter |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group expects the sales volume for the first quarter to increase no less than 17% Y-o-Y to no less than HK$860 million. more info >> |
|
| Monday, July 18, 2022 |
|
|
医思健康向恒生银行Signature优卓理财及优越理财客户提供医疗保健服务 |
| 香港最大非医院医疗服务机构*──医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团透过旗下纽约医疗集团，发森，DR REBORN及ATO HAIR CLUB向恒生银行Signature优卓理财及优越理财客户提供多样化医疗保健服务。 more info >> |
|
|
醫思健康向恒生銀行Signature優卓理財及優越理財客戶提供醫療保健服務 |
| 香港最大非醫院醫療服務機構*──醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團透過旗下紐約醫療集團，髮森，DR REBORN及ATO HAIR CLUB向恒生銀行Signature優卓理財及優越理財客戶提供多樣化醫療保健服務。 more info >> |
|
|
EC Healthcare Provides Healthcare Services for Signature and Prestige Banking Customers of Hang Seng Bank |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* more info >> |
|
| Thursday, June 30, 2022 |
|
|
EC Healthcare and Yoho Group Form Strategic Partnership |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group signed a memorandum of understanding with Yoho Group Holdings Limited ("Yoho Group", SEHK stock code: 2347) for a strategic collaboration. more info >> |
|
|
医思健康与友和集团建立战略合作伙伴关系 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团与友和集团控股有限公司（「友和集团」；香港联交所股份编号：2347）就拟建立战略合作伙伴关系签署谅解备忘录。 more info >> |
|
|
醫思健康與友和集團建立戰略合作夥伴關係 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團與友和集團控股有限公司（「友和集團」；香港聯交所股份編號：2347）就擬建立戰略合作夥伴關係簽署諒解備忘錄。 more info >> |
|
| Monday, June 27, 2022 |
|
|
医思健康荣获《机构投资者》2022亚洲区最佳管理团队多个奖项 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然公布集团于国际金融权威杂志《机构投资者》发布的2022年度「亚洲区最佳管理团队」榜单中荣获医疗健康及制药类别多个奖项。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
GEON Performance Solutions Achieves Great Place to Work Recognition Globally Second Year in a Row
Aug 13, 2025 14:18 HKT/SGT
|
|
|
China Lilang Announces 2025 Interim Results
Aug 13, 2025 14:15 HKT/SGT
|
|
|
Natural Beauty 2025 Interim Profit Surges by 136% to HK$11 Million
Aug 13, 2025 14:13 HKT/SGT
|
|
|
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
Aug 13, 2025 14:00 HKT/SGT
|
|
|
74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong
Aug 13, 2025 12:00 HKT/SGT
|
|
|
AI Inference vs. AI Training: What Are the Differences?
Aug 13, 2025 11:00 HKT/SGT
|
|
|
Shoucheng Joins World Humanoid Robot Games - 88 Spectators Invited
Aug 13, 2025 10:15 HKT/SGT
|
|
|
首程控股(0697.HK)抽取88位幸運觀眾現場觀賽 深度參與世界人形機器人運動會
Aug 13, 2025 09:58 HKT/SGT
|
|
|
首程控股(0697.HK)抽取88位幸运观众现场观赛 深度参与世界人形机器人运动会
Aug 13, 2025 09:43 HKT/SGT
|
|
|
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
Aug 13, 2025 09:27 HKT/SGT
|
|
|
康基醫療收到由董事長鍾鳴、TPG及卡塔爾投資局(QIA)牽頭財團提出之私有化要約 助力公司實現長遠願景
Aug 13, 2025 09:27 HKT/SGT
|
|
|
康基医疗收到由董事长钟鸣、TPG及卡塔尔投资局(QIA)牵头财团提出的私有化要约 助力公司实现长远愿景
Aug 13, 2025 09:27 HKT/SGT
|
|
|
T-RIZE Group Lists $RIZE Token on Revolut App, Expanding Global Access to Tokenized Real-World Assets
Aug 13, 2025 07:30 HKT/SGT
|
|
|
Formerra 成為 Syensqo PVDF 的北美區經銷商
Aug 13, 2025 07:00 HKT/SGT
|
|
|
Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan
Aug 12, 2025 22:20 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
